Genomic deletions at 1p and 14q are associated with an abnormal cDNA microarray gene expression pattern in meningiomas but not in schwannomas

Cancer Genetics and Cytogenetics

Volumn 196, Issue 1, 2010, Pages 1-6

  Martínez Glez, Victor ^a   Alvarez, Luis ^a   Franco Hernández, Carmen ^a   Torres Martin, Miguel ^a   de Campos, Jose M ^b   Isla, Alberto ^a   Vaquero, Jesús ^c   Lassaletta, Luis ^a   Castresana, Javier S ^d   Casartelli, Cacilda ^e   Rey, Juan A ^a  

^a HOSPITAL UNIVERSITARIO LA PAZ   (Spain)

^b Instituto Reina Sofía de Investigación Nefrológica   (Spain)

^c HOSPITAL UNIVERSITARIO PUERTA DE HIERRO   (Spain)

^d UNIVERSITY OF NAVARRA   (Spain)

^e UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA; RNA;

ARTICLE; CHROMOSOME 14Q; CHROMOSOME 1P; CONTROLLED STUDY; DNA MICROARRAY; GENE DELETION; GENE EXPRESSION; GENE FREQUENCY; GENE IDENTIFICATION; GENE LOCATION; GENE LOSS; GENE STRUCTURE; GENETIC ANALYSIS; GENETIC DISORDER; HUMAN; HUMAN CELL; HUMAN TISSUE; MENINGIOMA; MICROARRAY ANALYSIS; MICROSATELLITE MARKER; MULTIPLEX LIGATION DEPENDENT PROBE AMPLIFICATION; NEURILEMOMA; PRIORITY JOURNAL;

CHROMOSOME DELETION; CHROMOSOMES, HUMAN, PAIR 1; CHROMOSOMES, HUMAN, PAIR 14; DNA, COMPLEMENTARY; GENE EXPRESSION PROFILING; GENOMICS; HUMANS; MENINGIOMA; NEURILEMMOMA; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS;

EID: 71149115701     PISSN: 01654608     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cancergencyto.2009.08.003     Document Type: Article

References (44)

1. In: Louis D.N., Ohgaki H., Wiestler O.D., and Cavenee W.K. (Eds). WHO Classification of tumours of the central nervous system (2007), IARC Press, Lyon
2. Kino T., Takeshima H., Nakao M., Nishi T., Yamamoto K., Kimura T., Saito Y., Kochi M., Kuratsu J., Saya H., and Ushio Y. Identification of the cis-acting region in the NF2 gene promoter as a target for mutation and methylation-dependent silencing in schwannoma. Genes Cells 6 (2001) 441-454
3. Gonzalez-Gomez P., Bello M.J., Alonso M.E., Lomas J., Arjona D., de Campos J.M., Vaquero J., Isla A., Lassaletta L., Gutierrez M., Sarasa J.L., and Rey J.A. CpG island methylation in sporadic and neurofibromatosis type 2-associated schwannomas. Clin Cancer Res 9 (2003) 5601-5606
4. Lomas J., Bello M.J., Arjona D., Alonso M.E., Martinez-Glez V., Lopez-Marin I., Amiñoso C., de Campos J.M., Isla A., Vaquero J., and Rey J.A. Genetic and epigenetic alteration of the NF2 gene in sporadic meningiomas. Genes Chromsomes Cancer 42 (2005) 314-319
5. Bello M.J., de Campos J.M., Kusak M.E., Vaquero J., Sarasa J.L., Pestaña A., and Rey J.A. Allelic loss at 1p is associated with tumor progression of meningiomas. Genes Chromosomes Cancer 9 (1994) 296-298
6. Simon M., von Deimling A., Larson J.J., Wellenreuther R., Kaslel P., Waha A., Warnick R.E., Tew J.M., and Menon A.G. Allelic losses on chromosomes 14, 10, and 1 in typical and malignant meningiomas: a genetic model of meningioma progression. Cancer Res 55 (1995) 4696-4701
7. Weber R., Bostrom J., Wolter M., Baudis M., Collins V.P., Reifenberger G., and Lichter P. Analysis of genomic alterations in benign, atypical, and anaplastic meningiomas: toward a genetic model of meningioma progression. Proc Natl Acad Sci USA 94 (1997) 14719-14724
8. Lamszus K., Kluwe L., Matschke J., Meissner R., and Westphal M. Allelic losses at 1p, 9q, 10q, 14q, and 22q in the progression of aggressive meningiomas and undifferentiated meningeal sarcomas. Cancer Genet Cytogenet 110 (1999) 103-110
9. Leone P.E., Bello M.J., de Campos J.M., Vaquero J., Sarasa J.L., Pestaña A., and Rey J.A. NF2 gene mutations and allelic status of 1p, 14q, and 22q in sporadic meningiomas. Oncogene 18 (1999) 2231-2239
10. Bello M.J., de Campos J.M., Vaquero J., Kusak M.E., Sarasa J.L., and Rey J.A. High-resolution analysis of chromosome arm 1p alterations in meningioma. Cancer Genet Cytogenet 120 (2000) 30-36
11. Cai D.X., Banerjee R., Schithauer B.W., Lohse C.M., Kleinschmidt-DeMasters B.K., and Perry A. Chromosome 1p and 14q FISH in clinicopathologic subsets of meningioma: diagnostic and prognostic implications. J Neuropathol Exp Neurol 60 (2001) 628-636
12. Murakami M., Hashimoto N., Takahashi Y., Hosokawa Y., Inazawa J., and Mineura K. A consistent region of deletion on 1p36 in meningiomas: identification and relation to malignant progression. Cancer Genet Cytogenet 140 (2003) 99-106
13. Lopez-Ginez C., Cerda-Nicolas M., Gil-Benso R., Callaghan R., Collado M., Roldan P., and Llombart-Bosch A. Association of loss of 1p and alterations of chromosome 14 in meningioma progression. Cancer Genet Cytogenet 148 (2004) 123-128
14. Tabernero M.D., Espinosa A.B., Maillo A., Sayagues J.M., Alguero M.C., Lumbreras E., Diaz P., Gonçalves J.M., Onzain I., Merino M., Morales F., and Orfao A. Characterization of chromosome 14 abnormalities by interphase in situ hybridization and comparative geneomic hybridization in 124 meningiomas. Am J Clin Pathol 123 (2005) 744-751
15. Leone P.E., Bello M.J., Mendiola M., Kusak M.E., de Campos J.M., Vaquero J., Sarasa J.L., Pestaña A., and Rey J.A. Allelic status of 1p, 14q and 22q and NF2 gene mutations in sporadic schwannomas. Int J Mol Med 1 (1998) 889-892
16. Martinez-Glez V., Franco-Hernandez C., Alvarez L., de Campos J.M., Isla A., Vaquero J., Lassaletta L., Casartelli C., and JÁ R. Meningiomas and schwannomas: Molecular subgroup classification found by expression arrays. Int J Oncology 34 (2009) 493-504
17. Mendiola M., Bello M.J., Alonso J., Leone P.E., Vaquero J., Sarasa J.L., Kusak M.E., de Campos J.M., Pestaña A., and Rey J.A. Search for mutations of the hRAD54 gene in sportadic menigniomas with deletion at 1p32. Mol Carcinogenesis 24 (1999) 300-304
18. Müller P., Henn W., Niedermayer I., Ketter R., Feiden W., Steudel W.-I., Zang K.D., and Steilin-Gimbel H. Deletion of chromosome 1p and loss of expression of alkaline phosphatase indicate progression of meningiomas. Clin Cancer Res 5 (1999) 3569-57
19. Leuraud P., Marie Y., Robin E., Huguet S., He J., Moktari K., Cornu P., Hoang-Xuan K., and Sanson M. Frequent loss of 1p32 region but no mutation of the p18 tumor suppressor gene in meningiomas. J Neurooncol 50 (2000) 207-213
20. INK4c gene in human meningiomas. Neurpathol Appl Neurobiol 26 (2000) 67-75
21. Alonso M.E., Bello M.J., Gonzalez-Gomez P., Lomas J., Arjona D., de Campos J.M., Kusak M.E., Sarasa J.L., Isla A., and Rey J.A. Mutation analysis of the p73 gene in nonastrocytic brain tumors. Br J Cancer 85 (2001) 204-208
22. INK4c) in atypical and anaplastic meningiomas. Am J Pathol 159 (2001) 661-669
23. Lomas J., Bello M.J., Arjona D., Gonzalez-Gomez P., Alonso M.E., de Campso J.M., Vaquero J., Ruiz-Barnes P., Sarasa J.L., Casartelli C., and Rey J.A. Analysis of the p73 gene in meningiomas with deletion at 1p. Cancer Genet Cytogenet 129 (2001) 88-91
24. Lomas J., Amiñoso C., Gonzalez-Gomez P., Alonso M.E., Arjona D., Lopez-Marin I., de Campos J.M., Isla A., Vaquero J., Gutierrez M., sarasa J.L., Bello M.J., and Rey J.A. Methylation status of TP73 in meningiomas. Cancer Genet Cytogenet 148 (2004) 148-151
25. Piaskowski S., Rieske P., Szybka M., Wozniak K., Bednarek A., Pluciennik E., Jaskolski D., Sikorska B., and Liberski P.P. GADD45A and EPB41 as tumor suppressor gene in meningioma pathogenesis. Cancer Genet Cytogenet 162 (2005) 63-67
26. Lusis E.A., Watson M.A., Chicoine M.R., Lyman M., Roerig P., Reifenberger G., Gutmann D.H., and Perry A. Integrative genomic analysis identifies NDRG2 as a candidate tumor suppressor gene frequently inactivated in clinically aggressive meningioma. Cancer Res 65 (2005) 7121-7126
27. Tse J.Y., Ng H.K., Lo K.W., Chong E.Y., Lam P.Y., Ng E.K., Poon W.S., and Huang D.P. Analysis of the cell cycle regulators p16INK4A, pRb, and CDK4 in low-and high-grade meningiomas. Hum Pathol 29 (1998) 1200-1207
28. Simon M., Park T.W., Koster G., Mahlberg R., Hackenbroch M., Loning T., and Schramm J. Alterations of INK4a/INK4b gene expression and telomerase activation in meningioma progression. J Neurooncol 55 (2001) 149-158
29. Bello M.J., Amiñoso C., Lopez-Marin I., Arjona D., Gonzalez-Gomez P., Alonso M.E., Lomas J., de Campos J.M., Kusak M.E., Vaquero J., Isla A., Gutierrez M., Sarasa J.L., and Rey J.A. DNA methylation of multiple promoter-associated CpG islands in meningiomas: relationship with the allelic status at 1p and 22q. Acta Neuropathol 108 (2004) 413-421
30. Liu Y., Pang J.C., Dong S., Mao B., Poon W.S., and Ng H.K. Aberrant CpG island hypermethylation profile is associated with atypical and anaplastic meningiomas. Hum Pathol 36 (2005) 416-425
31. Anselmo N.P., Bello M.J., Gonzalez-Gomez P., and AraujoDias L.A. Walter de Almeida JR, dos Santos MJ, Rey JA, Casartelli C. Epigenetic alterations in human brain tumors in a Brazilian population. Genetics Mol Biol 29 (2006) 413-422
32. Lassaletta L., Bello M.J., Del Rio L., Alfonso C., Roda J.M., Rey J.A., and Gavilan J. DNA methylation of multiple genes in vestibular schwannoma: relationship with clinical and radiological findings. Otol Neurotol 27 (2006) 1180-1185
33. Bello M.J., Martinez-Glez V., Franco-Hernandez C., Peña-Granero C., de Campos J.M., Isla A., Lassaleta L., Vaquero J., and Rey J.A. DNA methylation pattern in 16 tumor-related genes in schwannomas. Cancer Genet Cytogenet 172 (2007) 84-86
34. Almeida L.O., Custodio A.C., Pinto G.R., Santos M.J., Almeida J.R.W., Clara C.A., Rey J.A., and Casartelli C. Polymorphisms and DNA methylation of gene TP53 associated with extra-axial brain tumors. Genetics Mol Res 8 (2009) 8-18
35. Watson M.A., Gutmann D.H., Peterson K., Chicoine M.R., Kleinschmidt-DeMasters B.K., Brown H.G., and Perry A. Molecular characterization of human meningiomas by gene expression profiling using high-density oligonucleotide microarrays. Am J Pathol 161 (2002) 665-672
36. Wrobel G., Roerig P., Kokocinski F., Neben K., Hahn M., Reifenberger G., and Lichter P. Microarray-based gene expression profiling of benign, atypical and anaplastic meningiomas identifies novel genes associated with meningioma progression. Int J Cancer 114 (2005) 249-256
37. Sayagues J.M., Tabernero M.D., Maillo A., Telles O., Espinosa A.B., Sarasquete M.E., Merino M., Rasillo A., Vera J.F., Santos-Briz A., de Alava E., Garcia-Macia M.C., and Orfao A. Microarray-based analysios of spinal versus intracranial meningiomas: different clinical, biological, and genetic characteristics associated with distinct patterns of gene expression. J Neuropathol Exp Neurol 65 (2006) 445-454
38. Carvalho L., Smirnov I., Baia G.S., Modrusan Z., Smith J.S., Jun P., Costello J.F., McDermott M.W., VandenBerg S.R., and Lal A. Molecular signatures define two main classes of meningiomas. Mol Cancer 6 (2007) 64
39. Welling D.B., Lasak J.M., Akhmametyeva E., Ghaheri B., and Chang L.S. cDNA microarray analysis of vestivular schwannomas. Otol Neurotol 23 (2002) 736-748
40. Hanemann C.O., Barlet-Kirbach B., Diebold R., Kampchem K., Langmesser S., and Utermark T. Differential gene expression between human schwannoma and control schwann cells. Neuropathol Appl Neurobiol 32 (2006) 605-614
41. Martinez-Glez V., Franco-Hernandez C., and Rey J.A. Microarray gene expression profiling in meningiomas and schwannomas. Curr Med Chem 15 (2008) 826-833
42. Martinez Glez V., Franco-Hernandez C., Lomas J., Peña-Granero C., de Campos J.M., Isla A., and Rey J.A. Multiplex ligation-dependent probe amplification (MLPA) screening in meningiomas. Cancer Genet Cytogenet 173 (2007) 170-172
43. Rey J.A., Bello M.J., de Campos J.M., Kusak E., and Moreno S. Chromosomal involvement secondary to-22 in human meningiomas. Cencer Genet Cytogenet 33 (1988) 275-290
44. Sherbet G.V. Metastasis promoter S100A4 is a potentially valuable molecular target for cancer therapy. Cancer Lett 280 (2009) 15-30